Skip to main content
TipRanks
Go Ultimate75% OFF

Medicinova (MNOV) Stock Statistics & Valuation Metrics

335 Followers

Total Valuation

Medicinova has a market cap or net worth of $71.47M. The enterprise value is $38.79T.

Market Cap
$71.47M
Enterprise Value
$38.79T

Share Statistics

Medicinova has 51,232,670 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
51,232,670
Owned by Insiders
12.25%
Owned by Institutions
12.63%

Financial Efficiency

Medicinova’s return on equity (ROE) is -0.29 and return on invested capital (ROIC) is -31.63%.

Return on Equity (ROE)
-0.29
Return on Assets (ROA)
-0.26
Return on Invested Capital (ROIC)
-31.63%
Return on Capital Employed (ROCE)
-0.32
Revenue Per Employee
68.28K
Profits Per Employee
-2.00M
Employee Count
6
Asset Turnover
0.01
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of Medicinova is -6.42. Medicinova’s PEG ratio is -0.74.

PE Ratio
-6.42
PS Ratio
76.38
PB Ratio
1.68
Price to FCF
-7.29
Price to Operating Cash Flow
-7.03
PEG Ratio
-0.74

Income Statement

In the last 12 months, Medicinova had revenue of 409.66K and earned -12.00M in profits. Earnings per share was -0.24.

Revenue
409.66K
Gross Profit
31.05K
Operating Income
-13.28M
Pretax Income
-11.99M
Net Income
-12.00M
EBITDA
-11.97M
Earnings Per Share (EPS)
-0.24

Cash Flow

In the last 12 months, operating cash flow was -9.79M and capital expenditures -7,924, giving a free cash flow of -9.80M billion.

Operating Cash Flow
-9.79M
Free Cash Flow
-9.80M
Free Cash Flow per Share
-0.20

Dividends & Yields

Medicinova pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-13.71%
Earnings Yield
-15.31%

Stock Price Statistics

Beta
0.57
52-Week Price Change
-9.42%
50-Day Moving Average
1.78
200-Day Moving Average
1.50
Relative Strength Index (RSI)
39.96
Average Volume (3m)
331.78K

Important Dates

Medicinova upcoming earnings date is ―, TBA (Confirmed).

Last Earnings Date
Apr 26, 2023
Next Earnings Date
―
Ex-Dividend Date
―

Financial Position

Medicinova as a current ratio of 8.16, with Debt / Equity ratio of 0.47%

Current Ratio
8.16
Quick Ratio
8.16
Debt to Market Cap
0.00
Net Debt to EBITDA
2.56
Interest Coverage Ratio
0.00

Taxes

In the past 12 months, Medicinova has paid 5,994 in taxes.

Income Tax
5,994
Effective Tax Rate
-0.00

Enterprise Valuation

Medicinova EV to EBITDA ratio is -3.98, with an EV/FCF ratio of -4.37.

EV to Sales
45.74
EV to EBITDA
-3.98
EV to Free Cash Flow
-4.37
EV to Operating Cash Flow
-4.37

Balance Sheet

Medicinova has $29.26M in cash and marketable securities with $590.63K in debt, giving a net cash position of $28.67M billion.

Cash & Marketable Securities
$29.26M
Total Debt
$590.63K
Net Cash
$28.67M
Net Cash Per Share
$0.56
Tangible Book Value Per Share
$0.54

Margins

Gross margin is 46.81%, with operating margin of -1232.17%, and net profit margin of -1127.01%.

Gross Margin
46.81%
Operating Margin
-1232.17%
Pretax Margin
-1126.37%
Net Profit Margin
-1127.01%
EBITDA Margin
-1148.27%
EBIT Margin
-1150.11%

Analyst Forecast

The average price target for Medicinova is $7.33, which is 11.43% higher than the current price. The consensus rating is Strong Buy

Price Target
$7.33
Price Target Upside
425.69% Upside
Analyst Consensus
Strong Buy
Analyst Count
3
Revenue Growth Forecast
262.80%
EPS Growth Forecast
12.54%

Scores

Smart Score
4
AI Score
―